ID
25714
Descripción
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Palabras clave
Versiones (1)
- 12/9/17 12/9/17 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
12 de septiembre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
final examination physical examination PK and tolerability of ropinirole as 5 new formulations 101468/197
final examination physical examination PK and tolerability of ropinirole as 5 new formulations 101468/197
Descripción
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Descripción
If Yes, Record below. Any clinically relevant worsening since the last examination must be recorded on the Adverse Event page.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0031809
- UMLS CUI [1,2]
- C0443172
Descripción
changes from last physical examination
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0031809
- UMLS CUI [1,2]
- C0443172
Similar models
final examination physical examination PK and tolerability of ropinirole as 5 new formulations 101468/197
C0443172 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])